Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine plus simethicone versus simethicone alone for upper endoscopy preparation
RBR-2n9x58kTerminated
- Sponsor
- IGESDF
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in gastric cancer (GC) comparing n-acetylcysteine + simethicone with simethicone alone (2 arms). Primary endpoint: Mean mucosal visibility score. Started Jul 2020; status: terminated.
02
Drugs
acetylcysteinesimethicone
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on RBR-2n9x58k.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2n9x58k.